Skip to main content
海圣医疗 logo

海圣医疗 — Investor Relations & Filings

Ticker · 920166 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 30 across all filing types
Latest filing 2026-03-11 Share Issue/Capital Cha…
Country CN China
Listing Beijing Stock Exchange 920166

About 海圣医疗

https://www.hisern.com/

Hisern Medical specializes in the research, development, and manufacturing of specialized medical devices, primarily focusing on anesthesia and critical care solutions. The company's product portfolio includes a comprehensive range of respiratory and anesthesia consumables, such as breathing circuits, laryngeal mask airways, endotracheal tubes, and anesthesia masks. Additionally, Hisern Medical provides advanced monitoring and delivery systems, including disposable pressure transducers and electronic infusion pumps. Committed to clinical safety and operational efficiency, the company utilizes advanced manufacturing technologies and rigorous quality control standards to support healthcare providers. Its solutions are engineered to enhance patient outcomes during surgical procedures and within intensive care environments through continuous technical innovation and a focus on clinical requirements.

Recent filings

Filing Released Lang Actions
关于变更公司注册资本、公司类型及修订公司章程的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding changes to the company's registered capital, company type, and amendments to the company's articles of association (company charter). It details the reasons for the amendments, specific changes to the articles, and references a board meeting resolution. The document does not contain financial statements or detailed financial performance data. It is a regulatory announcement about corporate governance and capital structure changes, specifically the increase in registered capital due to a new stock issuance and related amendments to the company charter. This fits best under the category of Share Issue/Capital Change (SHA), as it involves changes in registered capital and company type due to a new share issuance.
2026-03-11 Chinese
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled "浙江海圣医疗器械股份有限公司关联交易管理制度" which translates to "Zhejiang Haisheng Medical Device Co., Ltd. Related Party Transaction Management System." It details the company's internal rules and procedures for managing related party transactions, including definitions, decision-making processes, disclosure requirements, and board and shareholder meeting voting procedures. The document references compliance with laws, stock exchange rules, and company bylaws. It is a governance-related document outlining internal policies rather than a financial report, announcement, or meeting material. It is not an annual or interim report, audit report, earnings release, or any form of shareholder meeting presentation or voting result. It is a governance information document describing the company's internal rules and governance practices regarding related party transactions. Therefore, the appropriate classification is Governance Information (CGR). The document length (4858 characters) and content support this classification with high confidence.
2026-03-11 Chinese
募集资金管理制度
Capital/Financing Update Classification · 95% confidence The document is titled '募集资金管理制度' which translates to 'Fundraising Capital Management System' and details the management and use of funds raised by the company. It includes sections on the storage, use, supervision, and changes in the use of raised funds. The document references the company's board meeting where the system was approved and mentions compliance with relevant laws and stock exchange rules. It is a detailed policy document related to capital management rather than a financial report or announcement of voting results. It does not contain financial statements or earnings data, nor is it a brief announcement or a presentation. It is a regulatory compliance document outlining internal controls and procedures for managing raised capital. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2026-03-11 Chinese
信息披露暂缓、豁免管理制度
Governance Information Classification · 95% confidence The document is a detailed company internal policy regarding information disclosure delay and exemption management, including procedures, scope, and responsibilities. It references regulatory frameworks and company governance but does not contain financial statements, earnings data, or shareholder voting results. It is not an announcement of a report publication but a governance-related document. The content aligns with governance information about internal rules and disclosure practices rather than a financial report or announcement. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 2655 characters, which is sufficient for a substantive policy document rather than a brief announcement.
2026-03-11 Chinese
中信证券股份有限公司关于浙江海圣医疗器械股份有限公司使用募集资金置换预先已投入募投项目及已支付发行费用的自筹资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the use of raised funds by Zhejiang Haisheng Medical Devices Co., Ltd. It discusses the company's public stock issuance, listing on the Beijing Stock Exchange, the amount of funds raised, and the use of those funds to replace self-raised capital previously invested in projects and issuance expenses. The document includes references to regulatory approvals, audit reports, board and committee approvals, and compliance with relevant securities regulations. It is not a full annual or interim financial report, nor is it a simple announcement or certification. Instead, it is a specialized audit or verification report related to the use of raised funds and compliance with regulatory requirements. Therefore, it fits best under the category of Audit Report / Information (AR). The document length is 4017 characters, which is sufficient for a detailed report but not a brief announcement. Hence, the classification is AR with high confidence. Q1 2026
2026-03-11 Chinese
关于浙江海圣医疗器械股份有限公司以自筹资金预先投入募投项目及支付发行费用的鉴证报告
Audit Report / Information Classification · 97% confidence The document is a CPA’s independent assurance (“鉴证报告”) on the company’s use of self-raised funds to pre-invest in projects and pay issuance fees. It is not announcing or attaching a report, nor is it a full annual or interim financial report, but a standalone audit/assurance report and special purpose statement under securities fundraising rules. Therefore, it fits the Audit Report / Information category. FY 2026
2026-03-11 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.